Twenty-four-hour serum growth hormone, insulin, C-peptide and blood glucose profiles and serum insulin-like growth factor-I concentrations in women with polycystic ovaries
- PMID: 1490653
- DOI: 10.1159/000182296
Twenty-four-hour serum growth hormone, insulin, C-peptide and blood glucose profiles and serum insulin-like growth factor-I concentrations in women with polycystic ovaries
Abstract
Raised insulin levels are now recognized as a characteristic feature of women with polycystic ovaries (PCO), and hyperinsulinism has been shown to stimulate androgen production in such women. We have, however, recently shown that hyperinsulinaemia is present only in the obese subjects with PCO in whom insulin concentrations correlate with those of luteinizing hormone. We therefore studied 24-hour blood profiles of growth hormone (GH) and insulin-like growth factor-I (IGF-I) in obese and non-obese women with PCO, for comparison with their levels of insulin, C-peptide and other hormones, such as androgens which are known to be disturbed in PCO. Mean 24-hour GH levels were higher overall in PCO than in control subjects, although the difference was not significant. When, however, a separate analysis was made in obese as compared with non-obese PCO patients, GH concentrations were significantly higher in the non-obese group than in the obese (p = 0.0005). There was a significant negative correlation between body mass index and mean 24-hour GH concentrations (r = -0.641; p = 0.0006). IGF-I concentrations were however similar in the PCO group overall and in controls, as well as in the obese and non-obese PCO patients. The 24-hour blood glucose profile pattern was significantly different in PCO women from controls (p = 0.009), with absence of post-prandial peaks in blood glucose concentrations. These changes were most marked in the non-obese PCO group, who also had significantly lower blood glucose levels than either controls or obese PCO subjects.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
An abnormality of the growth hormone/insulin-like growth factor-I axis in women with polycystic ovary syndrome due to coexistent obesity.J Clin Endocrinol Metab. 1992 Jun;74(6):1432-5. doi: 10.1210/jcem.74.6.1534330. J Clin Endocrinol Metab. 1992. PMID: 1534330
-
Overnight secretion pattern of growth hormone, sex hormone binding globulin, insulin-like growth factor-1 and its binding protein in obese and non-obese women with polycystic ovarian disease.Isr J Med Sci. 1994 Jan;30(1):42-7. Isr J Med Sci. 1994. PMID: 7511134
-
[Correlation between hormonal and metabolic profiles in women with polycystic ovary syndrome].Minerva Endocrinol. 1992 Jan-Mar;17(1):21-9. Minerva Endocrinol. 1992. PMID: 1495451 Italian.
-
Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.J Clin Endocrinol Metab. 1996 Aug;81(8):2854-64. doi: 10.1210/jcem.81.8.8768842. J Clin Endocrinol Metab. 1996. PMID: 8768842
-
Polycystic ovaries in non-obese and obese patients: possible pathophysiological mechanism based on new interpretation of facts and findings.Hum Reprod. 1993 Mar;8(3):379-84. doi: 10.1093/oxfordjournals.humrep.a138055. Hum Reprod. 1993. PMID: 7682564
Cited by
-
Oxidative Stress and Low-Grade Inflammation in Polycystic Ovary Syndrome: Controversies and New Insights.Int J Mol Sci. 2021 Feb 7;22(4):1667. doi: 10.3390/ijms22041667. Int J Mol Sci. 2021. PMID: 33562271 Free PMC article. Review.
-
Growth-hormone response to combined stimulation with GHRH plus GH-releasing peptide-6 in obese patients with polycystic ovary syndrome before and after short-term fasting.J Endocrinol Invest. 2003 Apr;26(4):333-40. doi: 10.1007/BF03345181. J Endocrinol Invest. 2003. PMID: 12841541 Clinical Trial.
-
In polycystic ovary syndrome, adrenal steroids are regulated differently in the morning versus in response to nutrient intake.Fertil Steril. 2010 Mar 1;93(4):1192-9. doi: 10.1016/j.fertnstert.2009.03.017. Epub 2009 Apr 1. Fertil Steril. 2010. PMID: 19342030 Free PMC article.
-
GH release after GHRH plus arginine administration in obese and overweight women with polycystic ovary syndrome.J Endocrinol Invest. 2003 Feb;26(2):117-22. doi: 10.1007/BF03345138. J Endocrinol Invest. 2003. PMID: 12739737
-
Nutrition, hormones, and breast cancer: is insulin the missing link?Cancer Causes Control. 1996 Nov;7(6):605-25. doi: 10.1007/BF00051703. Cancer Causes Control. 1996. PMID: 8932921 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical